The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Xocova
Ensitrelvir · ENSITRELVIR 125 mg/1 · Tablet · Oral · Shionogi Inc.
NDC 59630-0711-07 · 1 BLISTER PACK in 1 CARTON / 7 TABLET in 1 BLISTER PACK · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA220442
- TE code
- —
- Approval date
- May 29, 2026
- Patents / exclusivity
- 3 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | NCE | May 29, 2031 |
| patent | 12559474 | May 1, 2042 |
| patent | 11814368 | May 1, 2042 |
| patent | 9150546 | Dec 12, 2030 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Ensitrelvir (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Catalent Pharma Solutions, LLC | ENSITRELVIR 125 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Shionogi Inc. | ENSITRELVIR 125 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Xocova — NDC 59630-0711-07," retrieved September 3, 2026, https://drugdashboards.com/drug/59630071107.
Free to cite with attribution — see how the data is put together.